Temat: "Gene Expression Regulation, Neoplastic" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Inhibition of NOS1 promotes the interferon response of melanoma cells.
Autorzy :: Chen X; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Zou Z; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Wang Q; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Gao W; First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450001, China.
Zeng S; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Ye S; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Xu P; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Huang M; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Li K; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Chen J; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Zhong Z; Guangzhou Hospital of integrated Traditional and West Medicine, Guangzhou, 510800, China.
Zhang Q; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China.
Hao B; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China. .
Liu Q; Cancer Research Institute, Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Shatai South Road, Baiyun District, 16, Guangzhou, 510515, China. .; Pingshan District People's Hospital of Shenzhen, Shenzhen, 518118, China. .; Pokaż więcej
Źródło :: Journal of translational medicine [J Transl Med] 2022 May 10; Vol. 20 (1), pp. 205. Date of Electronic Publication: 2022 May 10.
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Melanoma, Experimental*
Animals ; Gene Expression Profiling ; Humans ; Interferons ; Mice ; Mice, Inbred C57BL ; Nitric Oxide Synthase Type I
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: circREEP3 Drives Colorectal Cancer Progression via Activation of FKBP10 Transcription and Restriction of Antitumor Immunity.
Autorzy :: Chen Z; School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
He L; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Zhao L; School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Zhang G; Department of Gastrointestinal Surgery, Henan Provincial People's Hospital, People's Hospital of Henan University, People's Hospital of Zhengzhou University, Zhengzhou, 450003, China.
Wang Z; School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Zhu P; School of Life Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Liu B; Research Center of Basic Medicine, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Pokaż więcej
Źródło :: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2022 May; Vol. 9 (13), pp. e2105160. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji :: Journal Article
MeSH Terms :: Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/metabolism
Colorectal Neoplasms*/pathology
Gene Expression Regulation, Neoplastic*/genetics
Carcinogenesis/genetics ; Cell Proliferation/genetics ; Humans ; RNA, Circular/genetics ; Tacrolimus Binding Proteins/genetics ; Tacrolimus Binding Proteins/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Regulatory functions of miR‑200b‑3p in tumor development (Review).
Autorzy :: Chen S; General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China.
Tu Y; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, P.R. China.
Yuan H; General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China.
Shi Z; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310014, P.R. China.
Guo Y; General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China.
Gong W; General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China.
Tu S; General Surgery, Cancer Center, Department of Colorectal Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang 310014, P.R. China.; Pokaż więcej
Źródło :: Oncology reports [Oncol Rep] 2022 May; Vol. 47 (5). Date of Electronic Publication: 2022 Mar 24.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Gene Expression Regulation, Neoplastic*
MicroRNAs*/genetics
MicroRNAs*/physiology
Neoplasms*/genetics
Humans ; Tumor Microenvironment/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer.
Autorzy :: Zhu H; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.
Jiang W; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.
Zhu H; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.
Hu J; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.
Tang B; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.
Zhou Z; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.
He X; Department of General Surgery, The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui 230001, P.R. China.; Pokaż więcej
Źródło :: International journal of oncology [Int J Oncol] 2022 May; Vol. 60 (5). Date of Electronic Publication: 2022 Mar 22.
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
ADAM12 Protein/*genetics
Stomach Neoplasms/*genetics
Cell Line, Tumor ; Humans ; Molecular Docking Simulation ; Prognosis ; Protein Interaction Maps ; Stomach Neoplasms/pathology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis.
Autorzy :: Yao Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China; Heilongjiang Province Key Laboratory of Tumor Immunology, China.
Liu C; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China; Heilongjiang Province Key Laboratory of Tumor Immunology, China.
Wang B; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Guan X; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Fang L; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Zhan F; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Sun H; School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Li H; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Lou C; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Yan F; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Lu X; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Cui L; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Liao Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Han S; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China.
Yao Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Heilongjiang Province Key Laboratory of Tumor Immunology, China; Heilongjiang Province Key Laboratory of Molecular Oncology, China. Electronic address: .
Zhang Y; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China; Translational Medicine Research and Cooperation Center of Northern China, Heilongjiang Academy of Medical Sciences, Harbin, China; Heilongjiang Province Key Laboratory of Tumor Immunology, China. Electronic address: .; Pokaż więcej
Źródło :: Cancer letters [Cancer Lett] 2022 May 01; Vol. 533, pp. 215595. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Pancreatic Neoplasms*/genetics
Animals ; Cell Cycle/genetics ; Cell Division ; Cell Line, Tumor ; Cell Proliferation ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Humans ; Mice ; Retinoblastoma-Like Protein p130/genetics
SCR Disease Name :: Pancreatic Carcinoma
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Zinc finger C3H1-type containing serves as a novel prognostic biomarker in human pan-cancer.
Autorzy :: Liang W; Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541000, China; College of Life Science, Guangxi Normal University, Guilin 541000, China. Electronic address: .
Chen W; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin 541000, China. Electronic address: .
Wei J; College of Life Science, Guangxi Normal University, Guilin 541000, China. Electronic address: .
Yao H; Biliary Hepatopancreatic Surgery, The Second Affiliated Hospital of Guilin Medical University, Guilin 541000, China. Electronic address: .
Shi J; Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541000, China. Electronic address: .
Hou X; Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541000, China. Electronic address: .
Deng Y; College of Life Science, Guangxi Normal University, Guilin 541000, China. Electronic address: .
Ou M; Central Laboratory, Guangxi Health Commission Key Laboratory of Glucose and Lipid Metabolism Disorders, The Second Affiliated Hospital of Guilin Medical University, Guilin 541000, China. Electronic address: .; Pokaż więcej
Źródło :: Gene [Gene] 2022 Apr 30; Vol. 820, pp. 146251. Date of Electronic Publication: 2022 Feb 04.
Typ publikacji :: Journal Article
MeSH Terms :: Biomarkers, Tumor*
Gene Expression Regulation, Neoplastic*
Zinc Fingers*
Neoplasms/*metabolism
Transcription Factors/*metabolism
Computational Biology ; Databases, Genetic ; Humans ; Neoplasms/diagnosis ; Prognosis
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: CoMI: consensus mutual information for tissue-specific gene signatures.
Autorzy :: Huang SH; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan.; Graphen Inc., New York, NY, 10110, USA.
Lo YS; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan.
Luo YC; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan.
Chuang YH; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan.
Lee JY; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan.
Yang JM; Institute of Bioinformatics and Systems Biology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan. .; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan. .; Center for Intelligent Drug Systems and Smart Bio-Devices, National Yang Ming Chiao Tung University, Hsinchu, 300193, Taiwan. .; Pokaż więcej
Źródło :: BMC bioinformatics [BMC Bioinformatics] 2022 Apr 19; Vol. 22 (Suppl 10), pp. 624. Date of Electronic Publication: 2022 Apr 19.
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Neoplasms*/genetics
Consensus ; Gene Expression Profiling ; Humans ; Precision Medicine
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 8 8.

Tytuł :: Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
Autorzy :: Tu J; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.; Department of Musculoskeletal Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
Huo Z; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.; Department of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
Yu Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Zhu D; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Xu A; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Huang MF; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030.
Hu R; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Wang R; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030.; Department of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Gingold JA; Department of Obstetrics & Gynecology and Women's Health, Einstein/Montefiore Medical Center, Bronx, NY 10461.
Chen YH; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Tsai KL; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030.; Department of Biochemistry and Molecular Biology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Forcioli-Conti NR; Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Huang SXL; Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Webb TR; Wildflower Biopharma Inc., Encinitas, CA 92024.
Su J; Accutar Biotechnology Inc., Brooklyn, NY 11226.
Bazer DA; Department of Neurology, Renaissance School of Medicine, Stony Brook University, Stony Brook, NY 11794.
Jia P; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Yustein JT; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX 77030.; The Faris D. Virani Ewing Sarcoma Center, Baylor College of Medicine, Houston, TX 77030.
Wang LL; Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030.
Hung MC; Graduate Institute of Biomedical Sciences, China Medical University, Taichung 404, Taiwan.; Center for Molecular Medicine, China Medical University, Taichung 404, Taiwan.; Department of Biotechnology, Asia University, Taichung 413, Taiwan.
Zhao Z; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030.; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Huff CD; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030.
Shen J; Department of Musculoskeletal Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.; Guangdong Provincial Key Laboratory of Orthopedics and Traumatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, P. R. China.
Zhao R; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.
Lee DF; Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX 77030.; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX 77030.; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030.; Center for Stem Cell and Regenerative Medicine, The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases, The University of Texas Health Science Center at Houston, Houston, TX 77030.; Pokaż więcej
Źródło :: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 Apr 19; Vol. 119 (16), pp. e2117857119. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji :: Journal Article
MeSH Terms :: Bone Neoplasms*/genetics
Bone Neoplasms*/pathology
Carcinogenesis*/genetics
E2F3 Transcription Factor*/genetics
E2F3 Transcription Factor*/metabolism
Gene Expression Regulation, Neoplastic*
Induced Pluripotent Stem Cells*/metabolism
Osteosarcoma*/genetics
Osteosarcoma*/pathology
Retinoblastoma Binding Proteins*/genetics
Retinoblastoma Binding Proteins*/metabolism
Spliceosomes*/genetics
Spliceosomes*/metabolism
Ubiquitin-Protein Ligases*/genetics
Ubiquitin-Protein Ligases*/metabolism
Genes, Retinoblastoma ; Humans ; Mutation ; Retinal Neoplasms/genetics ; Retinoblastoma/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Identification of a 5-Nutrient Stress-Sensitive Gene Signature to Predict Survival for Colorectal Cancer.
Autorzy :: Xiong J; Department of Cardiovascular Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430071, China.
Xiong S; Department of Gastroenterology, Zhijiang People's Hospital, Yichang 443000, China.
Feng X; Department of Cardiovascular Medicine, Liyuan Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei 430071, China.
Zhang H; Clinical Cardiovascular Center, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430071 Hubei, China.
Su Q; Department of Clinical Laboratory, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi, China.; Pokaż więcej
Źródło :: BioMed research international [Biomed Res Int] 2022 Apr 18; Vol. 2022, pp. 2587120. Date of Electronic Publication: 2022 Apr 18 (Print Publication: 2022).
Typ publikacji :: Journal Article
MeSH Terms :: Colorectal Neoplasms*/pathology
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Chromosomal Proteins, Non-Histone/genetics ; Humans ; Nutrients ; Prognosis ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 10 10.

Tytuł :: Identification of Signature Genes and Construction of an Artificial Neural Network Model of Prostate Cancer.
Autorzy :: Dong H; Department of Kidney Disease and Blood Purifification Center, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Wang X; Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.; Pokaż więcej
Źródło :: Journal of healthcare engineering [J Healthc Eng] 2022 Apr 07; Vol. 2022, pp. 1562511. Date of Electronic Publication: 2022 Apr 07 (Print Publication: 2022).
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Prostatic Neoplasms*/genetics
Humans ; Male ; Neural Networks, Computer ; Prostate
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Prediction of Survival Rate and Chemotherapy Effect by an Immune Score Model in Colorectal Cancer.
Autorzy :: Liu S; Department of Anesthesiology, Dalian Women and Children's Medical Group, Dalian, Liaoning 116000, China.
Wang Z; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China.
Ntim M; Department of Physiology, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Han J; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China.
Jiang X; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China.
Fang C; Department of Gastroenteric Hernia Surgery, Ganzhou Hospital Affiliated to Nanchang University, Jiangxi 341000, China.
Xu C; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116000, China.
Zhang J; Department of Digestive Endoscopy, Dalian Municipal Central Hospital, Dalian, Liaoning 116000, China.; Pokaż więcej
Źródło :: BioMed research international [Biomed Res Int] 2022 Apr 04; Vol. 2022, pp. 8219701. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022).
Typ publikacji :: Journal Article
MeSH Terms :: Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/genetics ; Humans ; Prognosis ; Survival Rate ; Tumor Microenvironment/genetics
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: Effect of FLOT2 Gene Expression on Invasion and Metastasis of Colorectal Cancer and Its Molecular Mechanism under Nanotechnology and RNA Interference.
Autorzy :: Zhong C; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Zheng F; Second Department of Cardiology, The Third Hospital of Nanchang, Nanchang 330009, China.
Ye S; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Gao G; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
He P; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Liu D; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Nanchang University, Nanchang 330006, China.; Pokaż więcej
Źródło :: BioMed research international [Biomed Res Int] 2022 Apr 04; Vol. 2022, pp. 2897338. Date of Electronic Publication: 2022 Apr 04 (Print Publication: 2022).
Typ publikacji :: Journal Article
MeSH Terms :: Colorectal Neoplasms*/genetics
Gene Expression Regulation, Neoplastic*
Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Gene Expression ; Humans ; Liposomes ; Nanotechnology ; Polylysine ; RNA Interference ; RNA, Messenger/genetics ; RNA, Small Interfering/genetics ; Silicon/metabolism
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Deciphering the roles of miR-16-5p in malignant solid tumors.
Autorzy :: Yang L; Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China; Graduate School of North China University of Science and Technology, Tangshan, Hebei, China.
Yang S; Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China; Graduate School of North China University of Science and Technology, Tangshan, Hebei, China.
Ren C; Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China; Graduate School of Hebei North University, Zhangjiakou, Hebei, China.
Liu S; Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China; Graduate School of Hebei North University, Zhangjiakou, Hebei, China.
Zhang X; Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China; Graduate School of Hebei North University, Zhangjiakou, Hebei, China.
Sui A; Department of Oncology, Hebei General Hospital, Shijiazhuang, Hebei, China. Electronic address: .; Pokaż więcej
Źródło :: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Apr; Vol. 148, pp. 112703. Date of Electronic Publication: 2022 Feb 08.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Gene Expression Regulation, Neoplastic*
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA.
Autorzy :: Yao J; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Hua X; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Shi J; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Hu X; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Lui K; The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
He K; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Mai J; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.
Lan T; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Lu M; Department of HBP SURGERY II, the Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, People's Republic of China.; Pokaż więcej
Źródło :: FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2022 Apr; Vol. 36 (4), pp. e22238.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*metabolism
Carcinoma, Hepatocellular/*secondary
Intracellular Signaling Peptides and Proteins/*genetics
Liver Neoplasms/*pathology
Proteoglycans/*metabolism
RNA, Long Noncoding/*genetics
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Cell Proliferation ; Disease Progression ; Epithelial-Mesenchymal Transition ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Male ; Mice ; Mice, Nude ; Proteoglycans/genetics ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the mediating Keap1 expression.
Autorzy :: Li P; Department of Thoracic Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China. .
Liu X; Department of Thoracic Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China.
Xing W; Department of Thoracic Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China.
Qiu H; Quality and Standards Academy, Shenzhen Technology University, Shenzhen, 518000, Guangdong, China.
Li R; Quality and Standards Academy, Shenzhen Technology University, Shenzhen, 518000, Guangdong, China.
Liu S; Department of Thoracic Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China.
Sun H; Department of Thoracic Surgery, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, 127 Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China.; Pokaż więcej
Źródło :: Molecular and cellular biochemistry [Mol Cell Biochem] 2022 Apr; Vol. 477 (4), pp. 1295-1308. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji :: Journal Article
MeSH Terms :: Cell Movement*
Cell Proliferation*
Gene Expression Regulation, Neoplastic*
Esophageal Neoplasms/*metabolism
Exosomes/*metabolism
Kelch-Like ECH-Associated Protein 1/*biosynthesis
MicroRNAs/*metabolism
Neoplasm Proteins/*biosynthesis
RNA, Neoplasm/*metabolism
Aged ; Cell Line, Tumor ; Esophageal Neoplasms/genetics ; Exosomes/genetics ; Female ; Humans ; Kelch-Like ECH-Associated Protein 1/genetics ; Male ; MicroRNAs/genetics ; Middle Aged ; Neoplasm Proteins/genetics ; RNA, Neoplasm/genetics
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: Somatic Mutations Enriched in Cis-Regulatory Elements Affect Genes Involved in Embryonic Development and Immune System Response in Neuroblastoma.
Autorzy :: Lasorsa VA; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy.
Montella A; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy.
Cantalupo S; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy.
Tirelli M; CEINGE Biotecnologie Avanzate, Napoli, Italy.; European School of Molecular Medicine, Università degli Studi di Milano, Milano, Italy.
de Torres C; Hospital Sant Joan de Déu, Developmental Tumor Biology Laboratory and Department of Oncology, Esplugues de Llobregat, Barcelona, Spain.
Aveic S; Neuroblastoma Laboratory, Istituto di Ricerca Pediatrica Fondazione Città della Speranza, Padova, Italy.; Department of Dental Materials and Biomaterials Research, RWTH Aachen University Hospital, Germany.
Tonini GP; Neuroblastoma Laboratory, Istituto di Ricerca Pediatrica Fondazione Città della Speranza, Padova, Italy.
Iolascon A; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy.
Capasso M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli Federico II, Napoli, Italy.; CEINGE Biotecnologie Avanzate, Napoli, Italy.; Pokaż więcej
Źródło :: Cancer research [Cancer Res] 2022 Apr 01; Vol. 82 (7), pp. 1193-1207.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Neuroblastoma*/pathology
DNA-Binding Proteins/genetics ; Embryonic Development ; Humans ; Immune System/pathology ; Mutation ; Transcription Factors/genetics ; Transcription Factors/metabolism
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells.
Autorzy :: Bhattacharya A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Fushimi A; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Yamashita N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Hagiwara M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Morimoto Y; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Rajabi H; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Long MD; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Abdulla M; Colorectal Research Chair, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ahmad R; Colorectal Research Chair, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Street K; Department of Data Science, Dana-Farber Cancer Institute, Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Liu T; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Kufe D; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Pokaż więcej
Źródło :: Molecular cancer research : MCR [Mol Cancer Res] 2022 Apr 01; Vol. 20 (4), pp. 556-567.
Typ publikacji :: Journal Article
MeSH Terms :: Chromatin Assembly and Disassembly*
Gene Expression Regulation, Neoplastic*
Carcinogenesis/genetics ; Chromatin/genetics ; Chromatin/metabolism ; Humans ; Male ; Mucin-1/metabolism ; Neoplastic Stem Cells/metabolism ; Oncogenes
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Systematic analysis of the expression and prognostic value of ITPR1 and correlation with tumor infiltrating immune cells in breast cancer.
Autorzy :: Han B; Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, China.
Zhen F; Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, China.
Zheng XS; Department of Reproductive Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Harbin, 150001, China.
Hu J; Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, China. .
Chen XS; Department of Breast Medical Oncology, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin, 150040, China. .; Pokaż więcej
Źródło :: BMC cancer [BMC Cancer] 2022 Mar 21; Vol. 22 (1), pp. 297. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Breast Neoplasms/*genetics
Breast Neoplasms/*immunology
Inositol 1,4,5-Trisphosphate Receptors/*genetics
Lymphocytes, Tumor-Infiltrating/*metabolism
Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Female ; Humans ; Middle Aged ; Prognosis ; RNA, Messenger/genetics
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity.
Autorzy :: Zhang X; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Li L; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Huang S; Department of General Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Liao W; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Li J; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Huang Z; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Huang Y; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Lian Y; Guangdong Provincial Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.; Pokaż więcej
Źródło :: Oxidative medicine and cellular longevity [Oxid Med Cell Longev] 2022 Mar 17; Vol. 2022, pp. 5322929. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).
Typ publikacji :: Journal Article
MeSH Terms :: Gene Expression Regulation, Neoplastic*
Microfilament Proteins*/genetics
Microfilament Proteins*/metabolism
Cell Transformation, Neoplastic/metabolism ; Contractile Proteins ; Humans ; Prognosis ; Tumor Microenvironment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Identification of Key Genes Associated with Brain Metastasis from Breast Cancer: A Bioinformatics Analysis.
Autorzy :: Zeng C; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China (mainland).; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (mainland).
Lin M; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China (mainland).; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (mainland).
Jin Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China (mainland).; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (mainland).
Zhang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China (mainland).; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China (mainland).; Pokaż więcej
Źródło :: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2022 Mar 17; Vol. 28, pp. e935071. Date of Electronic Publication: 2022 Mar 17.
Typ publikacji :: Journal Article
MeSH Terms :: Down-Regulation*
Gene Expression Regulation, Neoplastic*
Up-Regulation*
Brain Neoplasms/*genetics
Breast Neoplasms/*genetics
Computational Biology/*methods
Oncogenes/*genetics
Brain Neoplasms/diagnosis ; Brain Neoplasms/secondary ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Female ; Gene Expression Profiling ; Gene Regulatory Networks ; Humans ; Neoplasm Metastasis ; Prognosis ; RNA, Neoplasm/genetics
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Gene Expression Regulation, Neoplastic"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język